Tenax Therapeutics (TENX) closed at $1.69 on November 10, 2026, down 5.1% from the previous close, on volume of 1,094,323 shares (30-day average 1,950,223).
Data as of November 10, 2026.
10-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 28, 2026 | Call Spread | 19-Jan-292 : 7.5 C | 320 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
Newsfile (Tue, 10-Nov 10:37 PM ET)
PRNewswire (Tue, 10-Nov 2:10 PM ET)
Globe Newswire (Tue, 10-Nov 11:54 AM ET)
Business Wire (Tue, 10-Nov 11:04 AM ET)
Globe Newswire (Tue, 10-Nov 10:25 AM ET)
Globe Newswire (Mon, 9-Nov 10:15 AM ET)
PRNewswire (Mon, 9-Nov 9:25 AM ET)
PRNewswire (Mon, 9-Nov 9:20 AM ET)
Business Wire (Mon, 9-Nov 7:45 AM ET)
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
Tenax Therapeutics trades on the NASDAQ stock market under the symbol TENX.
As of November 10, 2026, TENX stock price declined to $1.69 with 1,094,323 million shares trading.
TENX has a beta of 0.40, meaning it tends to be less sensitive to market movements. TENX has a correlation of 0.00 to the broad based SPY ETF.
TENX has a market cap of $76.96 million. This is considered a Micro Cap stock.
In the last 3 years, TENX traded as high as $61.20 and as low as $1.31.
The top ETF exchange traded funds that TENX belongs to (by Net Assets): IWM, VTI, IWN, VXF, VTWO.
TENX has underperformed the market in the last year with a return of -75.8%, while SPY returned +11.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in TENX shares. However, TENX has outperformed the market in the last 3 month and 2 week periods, returning +22.9% and -1.7%, while SPY returned -2.7% and -2.6%, respectively. This indicates TENX has been having a stronger performance recently.
TENX support price is $1.67 and resistance is $1.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TENX shares will trade within this expected range on the day.
